Disclosure Information

In accordance with the ACCME Accreditation Criteria, the American College of Surgeons must ensure that anyone in a position to control the content of the educational activity (planners and speakers/authors/discussants/moderators) has disclosed all financial relationships with any commercial interest (termed by the ACCME as “ineligible companies”, defined below) held in the last 24 months (see below for definitions). Please note that first authors were required to collect and submit disclosure information on behalf all other authors/contributors, if applicable.

Ineligible company

The ACCME defines an “ineligible company” as any entity producing, marketing, re-selling, or distributing health care goods or services used on or consumed by patients. Providers of clinical services directly to patients are NOT included in this definition.

Financial Relationships

Relationships in which the individual benefits by receiving a salary, royalty, intellectual property rights, consulting fee, honoraria, ownership interest (e.g., stocks, stock options or other ownership interest, excluding diversified mutual funds), or other financial benefit.  Financial benefits are usually associated with roles such as employment, management position, independent contractor (including contracted research), consulting, speaking and teaching, membership on advisory committees or review panels, board membership, and other activities from which remuneration is received, or expected.  

Conflict of Interest

Circumstances create a conflict of interest when an individual has an opportunity to affect CME content about products or services of an ineligible company with which he/she has a financial relationship.

The ACCME also requires that ACS manage any reported conflict and eliminate the potential for bias during the educational activity.  Any conflicts noted below have been managed to our satisfaction. The disclosure information is intended to identify any commercial relationships and allow learners to form their own judgments. However, if you perceive a bias during the educational activity, please report it on the evaluation. 

Planning Committee Disclosures

Cherise Berry - Nothing to Disclose
Wendy Greene - Nothing to Disclose
Orlando Kirton - Nothing to Disclose
Valentine Nfosom - Nothing to Disclose
Susan Pories - Nothing to Disclose
Bonnie Mason - Nothing to Disclose

Author Disclosures

Tania Aurora - Nothing to Disclose    
Bernadette Aulivola - Nothing to Disclose    
Douglas Bernhart - Nothing to Disclose    
Carol Berry - Nothing to Disclose    
Stephanie Bonne - Nothing to Disclose    
Paris Butler - Nothing to Disclose    
Jo Buyski - Nothing to Disclose    
Steven Chao - Nothing to Disclose    
Shajeel Chaudhry - Nothing to Disclose    
Herbert Chen - Nothing to Disclose    
Karen Chojnacki - Nothing to Disclose    
Callisia Clarke - Nothing to Disclose    
Scott Coates - Nothing to Disclose    
Marie Crandall - Nothing to Disclose    
Dee Das - Nothing to Disclose    
Kimberly Davis - Nothing to Disclose    
Cori DeLisi - Nothing to Disclose    
Daniel Dent - Nothing to Disclose    
Rochelle Dicker - Nothing to Disclose
Vikas Dudeja - Nothing to Disclose
Bridget Fahy - UnitedHealth Group Incorporated/stock ownership; IDEXX LABORATORIES INC COM USD0.1/stock ownership; Shockwave Medical, Inc./stock ownership; MASIMO CORP stock ownership; Repligen Corporation stock ownership; Veeva Systems Inc Class A stock ownershipBRISTOL-MYERS SQUIBB CO COM stock ownership; VANGUARD INDEX FUNDS S&P 500 ETF USD/stock ownership; Globus Medical Inc Class A stock ownership; Moderna, Inc./stock ownership; STAAR Surgical Company/stock ownership; ResMed Inc./stock ownership; TELADOC HEALTH INC COM/stock ownership; Guardant Health, Inc./ stock ownership; Fulgent Genetics, Inc./stock ownership; Seagen, Inc./stock ownership; IIntuitive Surgical, Inc./stock ownership; HCA Healthcare Inc/stock ownership; DexCom, Inc./stock ownership; Neurocrine Biosciences, Inc./stock ownership; Biogen Inc./stock ownership; EDITAS MEDICINE INC COM/stock ownership; Align Technology, Inc./stock ownership; GoodRx Holdings, Inc. Class A/stock ownership    
Mary Fallat - Nothing to Disclose    
Diana Farmer - BrioPryme Biologics- Stock options, Consultant
Paula Ferrada - Nothing to Disclose    
Nancy Gantt - Nothing to Disclose    
Nicole Goulet - Nothing to Disclose    
Randolph Guzman - Nothing to Disclose    
Chelsa Harris - Nothing to Disclose    
Alexandra Hernandez - Nothing to Disclose    
O'Joe Hines - Nothing to Disclose    
Julie Hong - Nothing to Disclose    
Yue-Yung Hu - Nothing to Disclose    
Marybeth Hughes - Nothing to Disclose
Benjamin Jarman - Nothing to Disclose    
D. Rohan Jeyarajah - Nothing to Disclose    
Andrew Jones - Nothing to Disclose    
Kathie-Ann Joseph - Nothing to Disclose    
Lawrence Kim - Nothing to Disclose    
Gifty Kwakye - Nothing to Disclose    
Keith Lillemoe - Nothing to Disclose    
Brenessa Lindeman - Nothing to Disclose    
Matthew Linz - Nothing to Disclose    
Kathryn Martin - Nothing to Disclose    
Matthew Martin - Nothing to Disclose    
Jeffrey Matthews - Nothing to Disclose    
Shyamin Mehra - Nothing to Disclose    
Alessandra Mele - Nothing to Disclose    
Harveshp Mogal - Nothing to Disclose    
Lilah Morris-Wiseman - Nothing to Disclose    
Heidi Nelson - Nothing to Disclose    
Erika Newman - Nothing to Disclose    
Benedict Nwomeh - Nothing to Disclose
Lynn O'Connor - Nothing to Disclose    
Kelsey Ogomori - Nothing to Disclose    
Ada Okafor - Nothing to Disclose    
Gezzer Ortega - Nothing to Disclose    
Sareh Parangi - Nothing to Disclose    
Caroline Prendergast - Nothing to Disclose    
Carla Pugh - Nothing to Disclose    
Carmen Ramos-Irizarry - Nothing to Disclose    
Erika Rangel - Nothing to Disclose    
Alisha Reiss - Nothing to Disclose    
Jorge Rodriguez - Nothing to Disclose
Sanziana Roman - Nothing to Disclose    
Mark Sawyer - Nothing to Disclose    
Fariha Sheikh - Nothing to Disclose    
Tiffany Sinclair - Nothing to Disclose    
Shannon Small - Nothing to Disclose    
Norma Smalls - Nothing to Disclose    
SchMiyah Smith - Nothing to Disclose    
Liem Snyder - Nothing to Disclose    
Julie Ann Sosa - Nothing to Disclose    
Sareh Suh - Nothing to Disclose    
Crystal Totten - Nothing to Disclose    
Xyruz Villariz - Nothing to Disclose    
Kasper Wang - Nothing to Disclose    
Tracy Wang - Nothing to Disclose    
William Ward - Nothing to Disclose    
Keyonna Williams - Nothing to Disclose    
Steven Xie - Nothing to Disclose    
Tonya Zakrison - Nothing to Disclose    

In our commitment to align diversity, equity and inclusion work being done across the college, the Office of Inclusive Excellence seeks to support, advise, or collaborate with internal and external stakeholders. At the conclusion of the Toolkit activity, learners will be able to:

• Identify why diversity, equity and inclusion is important to all members of the College.
• Define diversity.
• Apply techniques for solving Inclusivity challenges in the workplace and patient populations.
• Identify and Address Inclusivity challenges in the surgical workplace and in educational forums.
• Implement standards of equity practices to effectively address specific Inclusivity issues.
• Learners will refine their knowledge of best practices for transitioning teams and organizations to a culture of inclusion and belonging.
• Learners will examine strategies to anticipate challenges and sustain positive gains within institutions.
• Learners will be able to apply confidence, empowerment, and knowledge, to speak on DEI topics effectively and become strong advocates and speakers in their respective areas.
• Learners will be able to create a positive community with peer-to-peer support to combat isolation.
• Learners will be able to apply knowledge to their environment/culture, and the space will be a great place to share best practices for equitable and inclusive patient care.
• Learners will be able to implement Equity Practices at respective accountability levels.

Contact

Please contact the Office of Inclusive Excellence at ACS-IE@facs.org with new or updated information on any of your diversity, equity and inclusion -related programs, projects, or initiatives.

For any technical questions, please contact us at learning@facs.org.

The target audience is intended for general public.